FDA Approves Biogen’s Drug for Rare Form of ALS
The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic …
The Food and Drug Administration on Tuesday authorized the first drug for a rare genetic …
Biogen said on Tuesday that it will replace its chief executive and effectively give up …
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.